Revvity Inc. (NYSE:RVTY) Stock Has Average Target Price of $116.57

Revvity Inc. (NYSE:RVTY) has received an average recommendation of “Hold” from the nineteen ratings firms that are currently covering the company, MarketBeat reports. Fourteen research analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12 month target price among brokers that have covered the stock in the last year is $116.57.

A number of research firms recently weighed in on RVTY. KeyCorp raised their price target on Revvity from $125.00 to $165.00 and gave the company an “overweight” rating in a report on Friday, September 4th. William Blair initiated coverage on Revvity in a research note on Monday. They issued an “outperform” rating on the stock. Sanford C. Bernstein began coverage on Revvity in a report on Friday, June 26th. They set a “market perform” rating and a $115.00 target price on the stock. TD Cowen restated a “buy” rating on shares of Revvity in a report on Wednesday, July 15th. Finally, Evercore restated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th.

Revvity Stock Performance

NYSE RVTY opened at $153.33 on Friday. The firm has a market cap of $17.11 billion, a price-to-earnings ratio of 73.02, a PEG ratio of 2.86 and a beta of 1.06. The company has a 50 day moving average of $130.08 and a 200-day moving average of $109.82. The company has a current ratio of 1.80, a quick ratio of 1.50 and a debt-to-equity ratio of 0.36. Revvity has a 1-year low of $81.22 and a 1-year high of $166.25.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. The company had revenue of $729.69 million during the quarter, compared to analysts’ expectations of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. Revvity’s quarterly revenue was down 1.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.18 earnings per share. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. On average, equities analysts forecast that Revvity will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Friday, October 23rd will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 23rd. Revvity’s dividend payout ratio (DPR) is presently 13.33%.

Insider Transactions at Revvity

In other news, insider Tajinder Vohra sold 7,330 shares of the company’s stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the transaction, the insider directly owned 6,635 shares in the company, valued at approximately $934,738.80. This represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Maxwell Krakowiak sold 1,631 shares of the company’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of $144.53, for a total transaction of $235,728.43. Following the transaction, the insider owned 14,781 shares in the company, valued at $2,136,297.93. The trade was a 9.94% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 9,130 shares of company stock valued at $1,290,745. Insiders own 0.85% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Central Pacific Bank Trust Division bought a new position in Revvity in the 3rd quarter valued at $621,000. QRG Capital Management Inc. increased its stake in shares of Revvity by 14.4% in the 2nd quarter. QRG Capital Management Inc. now owns 5,881 shares of the company’s stock valued at $654,000 after buying an additional 742 shares during the period. State Street Corp raised its position in shares of Revvity by 0.8% during the second quarter. State Street Corp now owns 4,342,739 shares of the company’s stock worth $483,173,000 after acquiring an additional 32,426 shares during the last quarter. The Manufacturers Life Insurance Company raised its position in shares of Revvity by 5.8% during the second quarter. The Manufacturers Life Insurance Company now owns 368,938 shares of the company’s stock worth $41,048,000 after acquiring an additional 20,278 shares during the last quarter. Finally, Integrated Wealth Concepts LLC acquired a new position in shares of Revvity during the second quarter valued at $171,000. Institutional investors and hedge funds own 86.65% of the company’s stock.

Revvity Company Profile

Revvity, Inc (NYSE:RVTY) is a life sciences and diagnostics company that provides technologies, products and services used in biological research, drug discovery, clinical testing and healthcare. The company serves pharmaceutical and biotechnology companies, academic and government research institutions, hospitals, clinical laboratories and other healthcare organizations.

Its portfolio includes instruments, reagents, consumables, software and related services for areas such as genomics, proteomics, cellular analysis, imaging and multiplex testing.